Suchergebnisse - "Mauss, Stefan"

PubPharm (313)

41

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

enthalten in: Advances in therapy | 2020

von Lampertico, P. | Mauss, S. | Persico, M. | +9

42

Correction to: Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

enthalten in: Advances in therapy | 2020

von Lampertico, P. | Mauss, S. | Persico, M. | +9

43

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

enthalten in: Advances in therapy | 2020

von Lampertico, P. | Mauss, S. | Persico, M. | +9

ErratumIn: Adv Ther. 2020 Sep 11;:. - PMID 32915409

44

A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress

enthalten in: Archives of virology | 2020

von Cázares-Cortazar, A. | Uribe-Noguez, L. | Mata-Marín, J. | +6

45

A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress

enthalten in: Archives of virology | 2020

von Cázares-Cortazar, A. | Uribe-Noguez, L. | Mata-Marín, J. | +6

46

A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress

enthalten in: Archives of virology | 2020

von Cázares-Cortazar, A. | Uribe-Noguez, L. | Mata-Marín, J. | +6

47

Reinfection With the Hepatitis C Virus in Men Who Have Sex With Men After Successful Treatment With Direct-acting Antivirals in Germany : Current Incidence Rates, Compared With Rates During the Interferon Era

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2020

von Ingiliz, P. | Wehmeyer, M. | Boesecke, C. | +11

48

Clinical and Patient-Reported Outcomes of Direct-Acting Antivirals for the Treatment of Chronic Hepatitis C Among Patients on Opioid Agonist Treatment : A Real-world Prospective Cohort Study

enthalten in: Open forum infectious diseases | 2020

von Schulte, B. | Schmidt, C. | Manthey, J. | +12

49

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

enthalten in: Advances in therapy | 2020

von Lampertico, P. | Mauss, S. | Persico, M. | +9

50

Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis

enthalten in: Advances in therapy | 2020

von Lampertico, P. | Mauss, S. | Persico, M. | +9